This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heavily ...
September 3, 2019 — Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug ...
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remain a ...
January 16, 2019 — Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational ...
December 14, 2018 – Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As ...
December 4, 2018 — New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt ...
May 30, 2018 — Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy ...
Over the last decade, there have been considerable developments in procedural techniques and technology facilitating the ...
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously ...
September 20, 2017 — Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the ...